FICPI is a global community, built on trusted relationships, which strengthens the practice of the independent IP attorney
Contents :
Join us at 9am (US Eastern) // 2pm (London) // 3pm (Paris) // 9pm (Beijing) // 11pm (Melbourne) on Wednesday 30 September 2020 for a live Webinar, the first in FICPI's new webinar series "Connect, Share & Grow", designed by FICPI's Study & Work Committee and Professional Excellence Committee.

This session is open to all interested parties, whether or not FICPI members.  

Webinar // Subject matter eligibility

Sharon Crane and Swarup Kumar, chairs of the webinar series, will introduce topics from FICPI’s Study & Work (CET) groups and the Professional Excellence Committee (PEC) that will be subject of future webinars in the series.  

Sharon Crane (Chair of the Biotechnology and Pharmaceuticals group) and Brett Slaney (Chair of the Software, High-Tech, and Computer Related Issues group) will introduce the topic of subject matter eligibility, as well as the speakers.

Biotechnology and Pharmaceuticals Study & Work Group

  • MaryAnne Armstrong (USA) will discuss the US Supreme Court and Federal Circuit decisions that have shaped the current challenges we face in defining what is, and what is not, patent eligible subject matter in the US.  She will also discuss the USPTO’s 101 examination guidelines and life sciences examples, as well as proposed legislation to clarify the metes and bounds of what subject matter is patent eligible in the US.
  • Serge Shahinian (Canada) will discuss the scope of patent eligible subject matter in Canada. While therapeutic methods are not patentable in Canada, he will discuss alternative “use” and “product for use” formats, touching on hot topics such as claiming antibodies, stem cells, diagnostic methods and personalised medicine.  He will also discuss a significant recent court decision regarding the determination of “essential” claim elements in assessing patent eligibility.

Software, High-Tech, and Computer Related Issues Study & Work Group
  • Chad Billings (USA) will discuss US Supreme Court jurisprudence, focusing on the Alice (the “two-part test”) and Berkheimer decisions.  He will also discuss the USPTO 101 examination guidelines with a view to their effects on examination of, and claiming high-tech inventions.  
  • Johan Örtenblad (Sweden) will discuss the framework for determining patent eligible subject matter in Europe, including established case law, recent case law, and updates on examination guidelines.  He will also discuss G 1/19, a referral to the Enlarged Board of Appeals at the EPO relating to the patentability of computer-implemented simulations.

There will be the opportunity to ask questions throughout this interactive session.  

These webinars are eligible for CLE certificates of attendance. 

Please share the details of this webinar with your friends and colleagues.      

Joining instructions:

Please click here to register for the webinar. 

To enjoy the full experience via the Zoom platform, join from a PC/laptop/tablet or smartphone.  We suggest joining the meeting 5 minutes beforehand to iron out any access or audio queries.

The recording will be made available on the FICPI website shortly after the session.

Click here to register for the webinar

Recent news

Click here for FICPI news

This is the first in a new 16-part series of webinars. We will keep you updated on dates and topics through mailings, FICPI's LinkedIn page and the website event listings
Contribute your views & news!

Please send your newsletter article or blog suggestions to the FICPI editor, on

If you prefer to talk through your idea, please call Catherine on (UK) 0800 998 7990 or (UK mobile) 0794 166 9925 or email Catherine to arrange a Zoom or other online call.

On-demand webinars

Follow the FICPI LinkedIn Page

Keep up to date with the latest news via FICPI's LinkedIn Page:
FICPI @ LinkedIn

Copyright © 2020 FICPI, All rights reserved.

Want to change how you receive these emails?

You can update your preferences or unsubscribe from this list.

To submit a story contact Catherine Dhanjal at

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
FICPI · c/o Winter Brandl · Bavariaring 10 · München 80336 · Germany